Clinical studies recruiting near Savannah

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · CenExel iResearch, LLC · Bristol-Myers Squibb · NCT06929273 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Memorial Health University Medical Center · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · NRG Oncology · NCT05624996 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Summit Cancer Care PC · Hoffmann-La Roche · NCT06793215 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Memorial Health University Medical Center · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Velocity Clinical Research - Savannah · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Nancy N. & J.C. Lewis Cancer and Research Pavillion - Resear · Merck Sharp & Dohme LLC · NCT07216703 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · PrECOG, LLC. · NCT06538038 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Chatham County Health Department · Gilead Sciences · NCT07645287 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Candler Hospital · Agendia · NCT03053193 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Memorial Health University Medical Center · Children's Oncology Group · NCT04322318 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · SWOG Cancer Research Network · NCT06769126 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Memorial Health University Hospital · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Memorial Health University Medical Center · NRG Oncology · NCT05174169 Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp
NA · Memorial Health University Medical Center · Medtronic Cardiac Ablation Solutions · NCT07298473 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Memorial University Medical Center /ID# 264081 · AbbVie · NCT04928846 ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · Memorial Health University Medical Center · American Thrombosis and Hemostasis Network · NCT04398628 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Memorial Health University Medical Center · Children's Oncology Group · NCT04293562 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · Georgia Skin & Cancer Clinic · Sun Pharmaceutical Industries, Inc. · NCT07133308 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Cenexel Iresearch - Savannah · Xenon Pharmaceuticals Inc. · NCT06775379 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · Alliance for Clinical Trials in Oncology · NCT04242095 A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Trea
Phase 2 · CenExel · atai Therapeutics, Inc. · NCT06524830 ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Phase 2 · Site 7141 · Alto Neuroscience · NCT07553637 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · National Cancer Institute (NCI) · NCT05256225 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · CenExeli Research LLC 1 · Intra-Cellular Therapies, Inc. · NCT06372964 Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Phase 3 · Research Site · AstraZeneca · NCT06079671

Look up another city

Look up another condition